- Home
- »
- Biotechnology
- »
-
Single-use Pump Market Size, Share & Trends Report, 2033GVR Report cover
Single-use Pump Market (2026 - 2033)
Size, Share & Trends Analysis Report By Product (Equipment, Accessories), By Material (Polypropylene (PP) Pumps, Polyethylene (PE) Pumps), By End Use, By Region, And Segment Forecasts
Market Size, 2025
$534.8MMarket Estimate, 2026
$593.3MMarket Forecast, 2033
$1,489.7MCAGR, 2026–2033
14.1%Single-use Pump Market Summary
The global single-use pump market size was valued at USD 534.8 million in 2025 and is projected to grow from USD 593.3 million in 2026 to USD 1,489.7 million by 2033, at a CAGR of 14.1% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 42.6% in 2025. The increasing need for single-use pumps across numerous applications, as well as the expanding number of biopharmaceutical businesses, are driving the expansion of this market.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,
Download Free Sample Report Key Market Trends & Insights
- By product: Equipment segment held the largest revenue share of over 75.0% in 2025.
- By material type: Polypropylene segment held the largest revenue share of over 52.3% in 2025.
- By end use: Biopharmaceutical & pharmaceutical companies segment held the largest revenue share of over 42.8% in 2025.
Regional Highlights
- Largest regional market: North America (42.6% revenue share, 2025)
- Fastest-growing regional market: Latin America (highest CAGR, 2026-2033)
- By country: The U.S. held the largest market share in 2025.
Market Size & Forecast
- Market size in 2025: USD 534.8 Million
- Estimated market size in 2026: USD 593.3 Million
- Projected market size by 2033: USD 1,489.7 Million
- CAGR (2026-2033): 14.1%
Prism AI by Grand View Research Free to tryAsk a question about the single-use pump marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →The COVID-19 pandemic prompted the pharmaceutical sector to ramp up manufacturing rapidly. Increased FDA approvals for biologics have increased biopharmaceutical development, especially within North America & Asia. With a surge in biopharmaceuticals demand expected over the next 5 to 7 years, demand for single-use solutions such as bioreactors, pumps, mixers, connectors, tubing, consumables, and other types of instruments is likely to grow.
To learn more about this report, Download Free Sample Report The rise in the geriatric population and the number of ailments has resulted in an upsurge in pharmaceutical demand. Since the pharmaceutical sector makes substantial use of single-use technology, the requirement for single-use pumps is predicted to rise. Furthermore, increased disposable income has encouraged the rise of the food and beverage as well as cosmetics industries. With the increasing usage of single-use pumps in the food & beverage and cosmetic and chemical industries, the single-use pump industry is expected to flourish during the forecast period.
Recent statistics highlight the growing burden of chronic diseases. According to the Centers for Disease Control and Prevention (CDC), six in ten adults in the United States live with at least one chronic disease, and four in ten are reported to have two or more chronic diseases. These conditions are the leading causes of death and disability in the country, accounting for 90% of the nation's $4.5 trillion in annual healthcare expenditures. Globally, the World Health Organization (WHO) 2023 reports that noncommunicable diseases (NCDs) are responsible for 74% of all deaths, with 77% of these deaths occurring in low- and middle-income countries.
The escalating incidence of chronic diseases necessitates efficient and reliable drug delivery systems, thereby propelling the demand for single-use pumps. Manufacturers are responding by developing innovative, user-friendly devices tailored to the needs of chronic disease management. For instance, wearable single-use pumps for insulin delivery are becoming increasingly popular among diabetic patients, offering improved mobility and quality of life. As the global healthcare landscape continues to grapple with the challenges posed by chronic diseases, the adoption of single-use technologies is expected to rise, further driving market growth.
Market Dynamics
The single-use pump market is witnessing steady growth, driven by the increasing adoption of disposable fluid-handling systems in biopharmaceutical and pharmaceutical manufacturing. Rising demand for contamination-free processing, growing production of biologics and advanced therapies, and the need to reduce cleaning and validation requirements are supporting market expansion. In addition, technological advancements in single-use pump designs, increasing investments in bioprocessing infrastructure, and the expansion of contract manufacturing activities are expected to further drive market growth over the forecast period.
The growing need for flexible, scalable manufacturing processes is a key driver of the single-use pump market, particularly as biopharmaceutical production shifts toward smaller batch sizes and highly variable production requirements. Traditional stainless-steel systems are often rigid, capital-intensive, and time-consuming to reconfigure, making them less suitable for modern biologics, personalized medicine, and multi-product facilities. Single-use pumps offer plug-and-play adaptability, enabling manufacturers to quickly switch between processes without extensive cleaning or validation, thereby improving operational agility and reducing downtime.
For instance, in April 2024, Xylem launched the Jabsco PureFlo 21 single-use pump for biopharmaceutical applications, featuring an integrated pressure relief valve that enhances operator safety, reduces contamination risk, and improves process efficiency. Such product advancements reflect the industry’s broader shift toward modular and scalable manufacturing platforms, enabling faster deployment of production capacity while maintaining strict sterility and regulatory compliance. This aligns with the growing demand for flexible bioprocessing solutions that can seamlessly support scale-up from clinical to commercial manufacturing in biologics and advanced therapies.
The risk of extractables and leachables (E&L) from polymer-based components remains a key restraint for the single-use pump market. Single-use pumps are manufactured using various plastic materials that may release trace chemical compounds when exposed to process fluids under specific operating conditions. These substances can potentially interact with sensitive biologics, affecting product quality, stability, and safety. As a result, biopharmaceutical manufacturers must conduct extensive E&L assessments and material compatibility studies, increasing validation time and development costs.
The growing complexity of biologics, cell therapies, and gene therapies has increased regulatory expectations for comprehensive E&L characterization throughout the manufacturing process. Manufacturers are therefore required to invest in advanced testing, documentation, and risk assessment to demonstrate the suitability of single-use components. While ongoing improvements in material science are helping mitigate these concerns, the need for rigorous qualification and regulatory compliance continues to slow adoption, particularly for critical bioprocessing applications.
Market Concentration & Characteristics
The single-use pump market is characterized by a high degree of innovation, with companies focusing on developing advanced materials, improved flow control mechanisms, and automation features. Innovation is driven by the demand for sterile and efficient fluid handling in biopharmaceutical and biotechnology applications. Continuous R&D efforts are also directed toward enhancing pump compatibility with a wide range of chemicals, reducing the risk of contamination, and improving scalability for diverse applications.
M&A activities in the single-use pump market are robust as companies seek to expand their product portfolios, gain access to new technologies, and strengthen their market positions. Strategic acquisitions of smaller, innovative firms by larger corporations are common, allowing established players to diversify their offerings and enter new regional markets. These activities also foster collaboration between industry players, accelerating the development of advanced single-use technologies.
To learn more about this report, Download Free Sample Report The market operates under stringent regulatory frameworks due to its critical role in the pharmaceutical and bioprocessing industries. Regulatory agencies like the FDA and EMA enforce guidelines to ensure product safety, sterility, and compliance with Good Manufacturing Practices (GMP). These regulations drive companies to invest in validation processes and quality assurance systems, thereby influencing product design and innovation.
Companies in the single-use pump industry are expanding their product lines to cater to diverse applications, including upstream and downstream bioprocessing, cell and gene therapy, and personalized medicine manufacturing. This expansion is propelled by the growing adoption of single-use technologies in research and manufacturing settings, with firms introducing pumps that cater to higher flow rates, enhanced precision, and broader chemical compatibility.
Regional expansion is a significant focus area, with companies targeting emerging markets in Asia-Pacific, Latin America, and the Middle East & Africa. The growing biopharmaceutical manufacturing capabilities in these regions, coupled with government incentives and rising demand for cost-effective and scalable solutions, are encouraging global players to establish local facilities and distribution networks. This trend ensures the widespread availability of single-use pump technologies across geographies.
Analyst Perspective
The single-use pump market is expected to witness steady growth, driven by the increasing adoption of single-use bioprocessing technologies in biopharmaceutical manufacturing, vaccine production, and cell & gene therapy. Growing demand for contamination-free fluid transfer, reduced cleaning requirements, and flexible manufacturing processes is accelerating the use of single-use pumps across upstream and downstream bioprocessing. Continuous advancements in pump design, material compatibility, and process automation are improving operational efficiency and product quality. In addition, expanding biologics production and investments in biopharmaceutical manufacturing capacity are expected to support long-term market growth, encouraging manufacturers to focus on innovation and high-performance single-use fluid handling solutions
Product Insights
Based on product, the equipment segment held the largest revenue share of over 75.0% in 2025, and it is expected to grow with the fastest CAGR over the forecast period. The segment is also projected to exhibit the fastest CAGR of 13.5% during 2025-2033. This is primarily attributed to factors such as the increasing adoption of single-use systems and technologies in pharmaceutical & biotech companies due to benefits such as lower initial investment and R&D costs, low costs for labor and supplies, growing demand for biologics, and rising demand for single-use pumps among end users.
Furthermore, the government has invested heavily in the development of COVID-19 vaccines, treatments, and diagnostic tests, which is projected to fuel the demand for single-use pumps, hence driving total market growth. For example, in March 2020, the Canadian government funded CAD 275 million (USD 205.92 million) for COVID-19 research and development initiatives such as diagnostics, antivirals, vaccines, & clinical trials.
End Use Insights
Based on end use, the biopharmaceutical & pharmaceutical companies segment held the largest revenue share of over 42.8% in 2025, and it is expected to grow with the fastest CAGR over the forecast period. The majority of popular biopharmaceutical manufacturing techniques necessitate the handling, transporting, processing, and purifying of large-molecule pharmaceuticals produced by living cells. These operations, which are carried out with materials in a liquid phase, necessitate the use of pumping technologies capable of providing volumetric consistency along with accuracy, adequate pressures & flow rates, and material compatibility. Thus, it will increase the adoption of single-use pumps in biopharmaceutical & pharmaceutical companies and further boost the single-use pump industry growth.
To learn more about this report, Download Free Sample Report In addition, products offered by major companies are also boosting market growth. For instance, in May 2019, Quattroflow announced the addition of the innovative QF30SU Single-Use Diaphragm Pump to its portfolio of single-use pumps. In November 2022, the company also launched an advanced QF5kSU Quaternary Diaphragm Pumps. The continuous development of novel products by manufacturers and their increasing adoption are likely to propel the single-use pump industry's growth.
Material Insights
Based on material type, the polypropylene segment held the largest revenue share of over 52.3% in 2025, accounting for the largest proportion of the market. A PP Pump is composed of polypropylene, a thermoplastic polymer. Due to its resistance to heat, chemicals, and corrosion, this type of pump is frequently used in the medical & biopharmaceutical industries. Thus, high demand and usage of the pp pump will contribute to the segment's continued expansion.
The Polyethylene (PE) pump segment is expected to grow at the fastest CAGR of 13.9% during 2025-2033. PE Pump, built from polyethylene, has a high corrosion resistance to hostile liquids and chemicals. It is frequently utilized in biopharmaceutical, medical, manufacturing sectors, and consumer goods industries. Furthermore, while there are numerous material alternatives on the market, polyethylene is among the most extensively used. Thus, the growing need for polyethylene in the single-use pump sector is expected to boost market expansion in the coming years.
Regional Insights
North America dominated the single-use pump market with the largest revenue share of 42.6% in 2025. This large share can be attributed to several factors, including the availability of various major manufacturers, cost-effectiveness of single-use pumps, increased process efficiency, increased sterility, and risk mitigation, stringent regulatory requirements, and regulatory compliance in North America.
To learn more about this report, Download Free Sample Report U.S. Single-use Pump Market Trends
The single-use pump market in the U.S. held the largest share in the North America region in 2025. The single-use pump market in the U.S. holds a significant share of the regional market that can be attributed to the presence of large-scale manufacturing facilities for biopharmaceuticals. The biopharmaceutical sector is considered the most R&D-intensive in the U.S., and its development is recognized as a high-impact factor in the industry. Hence, it is expected to drive the adoption of single-use pump in the coming decade for a flexible and fast approach, leading to significant revenue generation in the U.S.
Europe Single-use Pump Market Trends
The single-use pump market in Europe is poised for significant growth, driven by increasing demand in the biopharmaceutical sector. Key factors contributing to this growth include the rising adoption of single-use technologies in manufacturing processes and the need for enhanced flexibility and efficiency in production.
The UK single-use pump market growth is driven by the rising demand for advanced medical technologies that address the growing prevalence of diseases in the country. In addition, local manufacturing initiatives supported by government incentives play a significant role in the UK market’s expansion as manufacturers have focused on strengthening domestic production to reduce dependency on imports and counter supply chain disruptions.
The single-use pump market in France has experienced significant growth due to the country's strong focus on sustainable and cost-effective fluid management solutions across various industries, including pharmaceuticals, biopharmaceuticals, and chemicals.
The single-use pump market in Germany is driven by the country's increasing focus on biotechnology and pharmaceutical manufacturing. Germany has a large number of bioprocessing facilities requiring advanced fluid handling solutions. Single-use pumps offer the flexibility and sterility needed in these environments, particularly for small-scale, personalized medicine production. The emphasis on minimizing cross-contamination and improving operational efficiency has further encouraged German manufacturers to adopt single-use technology.
Asia Pacific Single-use Pump Market Trends
The market growth in the region is mainly driven by factors such as increasing industrialization in sectors such as pharmaceuticals, food processing, and biotechnology. There has been a rapid growth of the pharma and biotech industries in this region. As these industries require high-quality standards and strict regulations, single-use pumps offer the benefits of sterility assurance, rapid changeovers, and ease of use nature of these single-use pumps. Moreover, many companies in the Asia-Pacific region focus on cost optimization in their manufacturing processes. Single-use pumps offer a perfect solution to reduce the cost while still maintaining the highest quality of standard. Considering these factors, many companies are encouraged to switch to single-use pumps thus pushing the single-use pump industry growth in the region.
The single-use pump market in China is expected to grow over the forecast period, driven by increasing investments in healthcare and biomedical research. China's expanding focus on advancing cancer research, genomics, and personalized medicine is fueling the demand for proteomics technologies. The expansion of the biopharmaceuticals sector in the country is driving the growth of the market in China. International companies are expanding their manufacturing facilities in this region through partnerships and collaborations with China-based companies. For instance, in April 2022, Merck entered into a partnership with the Administrative Management Committee of Wuxi National for the development of the first single-use manufacturing center by Merck in Asia Pacific.
The single-use pump market in India is expected to witness growth due to the increasing presence of a substantial number of contract and in-house manufacturers in the country. For instance, in February 2022, Cytiva signed an MoU with Bangalore Bioinnovation Centre (BBC), India, to offer a platform for skill development in the bioprocessing field. Such initiatives undertaken by various entities are expected to enhance the Indian market on the global platform.
Middle East & Africa Single-use Pump Market Trends
The Middle East & Africa (MEA) market for single-use bioprocessing is experiencing significant growth due to the increasing demand for biopharmaceuticals, the need for more efficient & cost-effective bioprocessing methods, and the expansion of the biopharmaceutical industry in the region.
The Saudi Arabia single-use pump market is experiencing significant growth, driven by increasing adoption of single-use technologies across the pharmaceutical, biotechnology, and chemical industries. Key trends include a rising focus on biopharmaceutical production, where single-use pumps are favored for their efficiency, reduced risk of cross-contamination, and lower operational costs.
The Kuwait single-use pump market is witnessing a growing demand for biopharmaceuticals, driven by an aging population, rising chronic disease prevalence, and the need for more advanced treatment options. Single-use technologies are crucial in the production of biopharmaceuticals, including vaccines, mAbs, and other therapeutic proteins.
Key Single-use Pump Company Insights
The market players operating in the single-use pump industry are adopting product approval as a strategy to increase the reach of their products in the market and improve the availability of their products in diverse geographical areas, along with expansion as a strategy to enhance production/research activities. In addition, several market players are acquiring smaller players to strengthen their market position. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve their competencies.
Key Single-Use Pump Companies:
The following key companies have been profiled for this study on the single-use pump market.
-
Dover Corporation
-
Spirax Group plc
-
Xylem
-
Levitronix
-
Stobbe Group
-
Getinge (High Purity New England)
-
Ace Sanitary
-
Verder Group (Verder Liquids)
-
Sartorius AG
-
Avantor Inc.
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (Dover Corporation, Spirax Group plc, Xylem, Sartorius AG, etc.)
Expand single-use pump portfolios through continuous product innovation, strategic partnerships, and integration with single-use bioprocessing workflows.
Broad bioprocessing expertise, global distribution networks, and strong relationships with leading biopharmaceutical manufacturers.
High dependence on biopharmaceutical manufacturing investments and biologics production demand.
Emerging Players (Levitronix, Stobbe Group, Getinge (High Purity New England))
Focus on specialized single-use pump technologies and customized fluid handling solutions for bioprocessing and aseptic manufacturing applications.
Strong technical expertise in specialized pumping technologies and application-specific fluid management solutions.
Limited global market reach and financial resources compared to diversified industry leaders.
Recent Developments
-
In October 2024, Avantor expanded its partnership with the National Institute for Bioprocessing Research and Training (NIBRT) to enhance biopharma manufacturing. This collaboration focuses on downstream optimization of monoclonal antibodies (mAbs) and includes the provision of Masterflex pump systems and single-use technologies to improve training and operational efficiency in biopharmaceutical workflows.
-
In June 2024, AdvantaPure, a unit of NewAge Industries, partnered with High Purity New England (HPNE) to distribute fluid transfer solutions in the Northeast U.S. This collaboration aims to enhance service quality in the biopharmaceutical sector.
-
In April 2024, Xylem launched the Jabsco PureFlo 21 Single Use diaphragm pump, featuring an integrated, adjustable pressure relief valve-the first of its kind in single-use pumping technology. This innovation enhances operator safety and reduces fluid contamination risks.
Single-use Pump Market Report Scope
Report Attribute
Details
Market size in 2025
USD 534.8 million
Estimated market size in 2026
USD 593.3 million
Projected market size by 2033
USD 1,489.7 million
Growth rate
CAGR of 14.1% from 2026 to 2033
Historical data
2021 - 2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Product, material type, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Norway, Denmark, Sweden, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, Saudi Arabia, South Africa, UAE, Kuwait
Key companies profiled
Dover Corporation, Spirax Group plc, Xylem, Levitronix, Stobbe Group, Getinge (High Purity New England), Ace Sanitary, Verder Group (Verder Liquids), Sartorius AG, Avantor Inc.
Customization scope
Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Single-use Pump Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research Inc. has segmented the global single-use pump market report based on product, material, end use, and region:
To learn more about this report, Download Free Sample Report -
Product Outlook (Revenue, USD Million, 2021 - 2033)
-
Equipment
-
Peristaltic pumps
-
Quaternary diaphragm pump
-
Centrifugal pumps
-
Others
-
-
Accessories
-
-
Material Outlook (Revenue, USD Million, 2021 - 2033)
-
Polypropylene (PP) Pumps
-
Polyethylene (PE) Pumps
-
Others
-
-
End-use Outlook (Revenue, USD Million, 2021 - 2033)
-
Biopharmaceutical & Pharmaceutical Companies
-
CROs & CMOs
-
Academic & Research Institutes
-
Others
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Research Methodology
The single-use pump market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each single-use pump segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment- Product
Revenue Capture Definition
Equipment
Revenue generated from single-use pump systems designed for sterile fluid transfer, dosing, recirculation, and process fluid management across biopharmaceutical manufacturing workflows. This segment includes peristaltic pumps for gentle fluid handling, diaphragm pumps for contamination-free transfer, centrifugal pumps for high-flow processing, and other single-use pumping technologies utilized in upstream and downstream bioprocessing, vaccine production, cell and gene therapy manufacturing, and aseptic filling applications.
Accessories
This segment captures income from components and replacement parts used to support the installation, operation, and maintenance of single-use pump systems. Products include tubing assemblies, connectors, manifolds, clamps, fittings, pump heads, sensor interfaces, and other disposable accessories designed to ensure sterile fluid transfer, operational flexibility, and compatibility with single-use bioprocessing systems.
Segment- Material Type
Revenue Capture Definition
Polypropylene
Revenue generated from single-use pump components manufactured using polypropylene, a material widely selected for its chemical resistance, mechanical strength, sterilization compatibility, and suitability for biopharmaceutical fluid handling applications.
Polyethylene
This segment captures income from single-use pump products fabricated from polyethylene, offering flexibility, chemical compatibility, low extractables, and reliable performance in sterile fluid transfer and disposable bioprocessing workflows.
Others
Market value in this category stems from single-use pump components produced using alternative polymer materials such as silicone, thermoplastic elastomers (TPE), fluoropolymers, and other specialty plastics selected to meet specific bioprocessing, pharmaceutical, and laboratory application requirements.
Segment- End Use
Revenue Capture Definition
Biopharmaceutical & Pharmaceutical Companies
Revenue generated from the adoption of single-use pump systems by pharmaceutical and biopharmaceutical manufacturers for biologics production, vaccine manufacturing, monoclonal antibody processing, cell and gene therapy production, and other sterile bioprocessing operations.
CROs & CMOs
This segment reflects earnings from contract research organizations (CROs) and contract manufacturing organizations (CMOs) utilizing single-use pumps to support outsourced research, process development, clinical manufacturing, commercial-scale biologics production, and flexible manufacturing services for multiple clients.
Academic & Research Institutes
Market value in this category stems from the use of single-use pump technologies by universities, research institutes, and government laboratories engaged in biotechnology research, process development, cell culture studies, and pilot-scale bioprocessing activities.
Other End-users
Revenue originates from hospitals, diagnostic laboratories, contract testing facilities, and other organizations employing single-use pump systems for specialized research, laboratory processing, biomanufacturing support, and sterile fluid handling applications.
Estimation Model
To learn more about this report, Download Free Sample Report Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Product & End-user Cross-Segmentation Analysis for Single-use Pumps
Detailed cross-segmentation analysis across pump types (peristaltic, quaternary diaphragm, centrifugal, and other equipment), materials (PP, PE, others), and end-use industries including biopharmaceutical & pharmaceutical companies, CROs & CMOs, and academic & research institutes. Assessment of adoption across upstream, downstream, fill-finish, and fluid transfer applications by region.
Identifies high-growth product-end user combinations, evaluates demand by bioprocessing workflow, uncovers expansion opportunities across biologics manufacturing, and supports product portfolio prioritization and commercialization strategies.
Competitive Benchmarking & Technology Positioning for Single-use Pump Manufacturers
Comprehensive benchmarking of leading manufacturers based on product portfolio, pump technology, material compatibility, flow performance, bioprocess application coverage, geographic presence, pricing strategy, distribution network, strategic collaborations, product launches, and manufacturing capabilities.
Enables clients to benchmark competitive positioning, identify technology gaps and innovation opportunities, evaluate partnership and acquisition targets, and refine market entry, product differentiation, and investment strategies.
Single-use Pump Application & Bioprocess Workflow Analysis
Customized assessment of single-use pump adoption across key bioprocess workflows including upstream processing, downstream purification, media and buffer preparation, fill-finish operations, and aseptic fluid transfer. Analysis includes application-wise demand, preferred pump technologies, material compatibility, and purchasing trends across biopharmaceutical manufacturers, CDMOs/CMOs, and research organizations.
Enables clients to identify the highest-growth bioprocess applications, optimize product positioning based on workflow requirements, align product development with evolving customer needs, and uncover commercialization opportunities across the biomanufacturing value chain.
Frequently Asked Questions About This Report
The global single-use pump market size was valued at USD 534.8 million in 2025 and is estimated at USD 593.3 million for 2026.
Some key players operating in the single-use pump market include Dover Corporation, Spirax Group plc, Xylem, Levitronix, Stobbe Group, Getinge (High Purity New England), Ace Sanitary, Verder Group (Verder Liquids), Sartorius AG, and Avantor Inc.
The increasing need for single-use pumps across numerous applications, as well as the expanding number of biopharmaceutical businesses, are driving the expansion of this market. Furthermore, rising demand for sterile along with disposable products is projected to fuel the expansion of this market.
The global single-use pump market is expected to grow at a CAGR of 14.1% from 2026 to 2033, reaching USD 1,489.7 million by 2033.
North America dominated with a 42.6% revenue share in 2025.
Latin America is the fastest-growing region over the forecast period.
The equipment segment led with a 75.0% revenue share in 2025.
The polypropylene segment led with a 52.3% revenue share in 2025.
The biopharmaceutical & pharmaceutical companies segment led with a 42.8% revenue share in 2025.
About the Author(s)
Biotechnology Research Team
Healthcare · BiotechnologyThis report was authored by the biotechnology research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the biotechnology segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
